• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Inari Medical(NARI.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Mar6
Inari Medical Launches Artix Thrombectomy System to Improve Outcomes for Arterial Thrombectomy Patients
18:38
Feb3
Halper Sadeh LLC Investigates Inari Medical, Inc. for Potential Violations of Securities Laws and Fiduciary Duties
19:02
Jan24
Kuehn Law Investigates Potential Claims Related to Mergers with Inari Medical and Others
15:02
Oct29
Inari Medical, Inc. announces positive results from the PEERLESS randomized controlled trial
16:01
Inari Medical released FY2024 9 Months Earnings on October 28 (EST), with actual revenue of 442.4 M USD and EPS of -1.2746 USD
03:00
Inari Medical released FY2024 Q3 earnings on October 28 (EST), actual revenue $153.39M (forecast $150.67M), actual EPS -$0.3146 (forecast -$0.1956)
03:00

Schedules & Filings

Schedules
Filings
Oct28
Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 153.39 M, Net Income -18.37 M, EPS -0.3146

Jul30
Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 145.82 M, Net Income -31.35 M, EPS -0.5399

Apr30
Earning Release(EST)

FY2024 Q1 Earning Release (USD) Revenue 143.19 M, Net Income -24.2 M, EPS -0.4199

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
10.075
+145.73%
+5.958
ANGH
3.770
+62.50%
+1.450
SIDU
4.140
+55.05%
+1.488
ESHA
22.110
+53.76%
+7.730
NCL
0.2718
+40.10%
+0.078
IPEXR
0.8400
+38.57%
+0.234
RDACR
0.2493
+31.21%
+0.059
ESHAR
0.2216
+30.35%
+0.052
VNDA
9.060
+28.88%
+2.020
LRE
1.640
+27.13%
+0.335
View More